Learn More
Echelon Biosciences Research Labs BrP-LPA 1 mg

Supplier: Echelon Biosciences Research Labs L74161MG
BrP-LPA, aka LPA bromophosphonate, acts as both an Autotaxin inhibitor (94% inhibition at 10 M) and pan LPA receptor antagonist (LPA1: 1.5 M, LPA2: 1.4 M, LPA3: 1.2 M, LPA4: 0.27 M). BrP-LPA inhibits the invasiveness of NIH3T3 ras ATX cells by 40% and decreases chemotaxis by 23%. BrP-LPA reduces the size of breast (MDA-MB-231), colon (HCT-116) and melanoma (B16F10) tumors in mouse models. It also attenuates collagen-induced arthritis PPAR is not activated by BrP-LPA. This item is non returnable
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.